Bank of America
UTHR icon

Bank of America’s United Therapeutics UTHR Stock Holding History

Bank of America’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,500
Closed -$645K – 7270
2017
Q3 		$645K Buy
+5,500
New +$702K ﹤0.01% 4810
2015
Q2 		– Sell
-30,000
Closed -$5.17M – 7417
2015
Q1 		$5.17M Buy
+30,000
New +$4.57M ﹤0.01% 2464
2014
Q4 		– Sell
-1,500
Closed -$193K – 7984
2014
Q3 		$193K Buy
1,500
+800
+114% +$82.5K ﹤0.01% 5416
2014
Q2 		$62K Sell
700
-700
-50% -$67.3K ﹤0.01% 6495
2014
Q1 		$132K Sell
1,400
-700
-33% -$71.6K ﹤0.01% 5755
2013
Q4 		$237K Sell
2,100
-800
-28% -$72.1K ﹤0.01% 5433
2013
Q3 		$229K Hold
2,900
– – ﹤0.01% 5343
2013
Q2 		$191K Buy
+2,900
New +$187K ﹤0.01% 5662

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of America's UTHR Position: Q1 2026 in Review

Bank of America reduced its United Therapeutics (UTHR) stake by 2.8% in Q1 2026, selling an estimated $2.84M and leaving 199,426 shares worth $118M. The position accounts for 0.01% of the portfolio, ranked #1000.

Bank of America first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. 852 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Bank of America held 199,426 shares of United Therapeutics worth $118M as of Q1 2026.
  • Bank of America sold 5,705 United Therapeutics shares in Q1 2026, an estimated $2.84M.
  • United Therapeutics made up 0.01% of Bank of America's portfolio in Q1 2026, its #1000 holding.
  • Bank of America first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
  • 852 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.